Scott Gottlieb: “How Medicare prices medical products and services has sweeping implications across the entire private market.”

IPAB has no obligation to engage in public notice and comment that is customary to regulatory agencies whose decisions have similarly broad implications.

Throughout my career I've worked to advance policies to enable terminally ill patients to obtain earlier access to promising new drugs.

IPAB was created based on a premise that decisions about the pricing of Medicare's benefits are simply too contentious to be handled by a political process.

I am committed to proper implementation of the TCA. As a physician and a cancer survivor, I am not going to countenance a rise in adolescent smoking rates in this country under my watch.